Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma

Published:2017-05-11 Issue:6 Volume:6 Page:1311-1322
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kim Seung Hyun¹^ORCID,Shin Kyoo-Ho¹,Moon Seong-Hwan¹,Jang Jinyoung¹,Kim Hyo Song²,Suh Jin-Suck³,Yang Woo-Ick⁴

Affiliation:

1. Department of Orthopedic Surgery; Yonsei University College of Medicine; Seoul Korea

2. Division of Medical Oncology; Department of Internal Medicine; Yonsei Cancer Center; Yonsei University College of Medicine; Seoul Korea

3. Department of Radiology and Research Institute of Radiological Science; Yonsei University College of Medicine; Seoul Korea

4. Department of Pathology; Yonsei University College of Medicine; Seoul Korea

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference45 articles.

1. Role of tumor markers in patients with solid cancers: a critical review;Duffy;Eur. J. Intern. Med.,2007

2. Clinical applications of serum tumor markers;Bates;Ann. Intern. Med.,1991

3. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience;Meyers;J. Clin. Oncol.,1992

4. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy;Bacci;Cancer,1993

5. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma;Liu;Oncology,1996

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological Response to Neoadjuvant Chemotherapy in Patients With Enneking Stage II Conventional Osteosarcoma of Extremities: A Retrospective-Single Institution Study in Vietnam;Cancer Control;2024-01

2. Predictive value of serum alkaline phosphatase, tumor-specific growth factor, and macrophage migration inhibitory factor for the efficacy of immunotargeted therapy in osteosarcoma patients;American Journal of Cancer Research;2024

3. An ALP-responsive, anionic iridium complex for specific recognition of osteosarcoma cells;Dalton Transactions;2024

4. Machine learning models based on routinely sampled blood tests can predict the presence of malignancy amongst patients with suspected musculoskeletal malignancy;Methods;2023-12

5. Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion;Cancer Medicine;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3